北京时间5月27日收盘,ZNTL市盈率为-28.01,ZNTL市值为14亿美元

ZNTL简介

ZentalisPharmaceuticals,Inc.isaclinical-stagebiopharmaceuticalcompanyfocusedondiscoveringanddevelopingsmallmoleculetherapeuticstargetingfundamentalbiologicalpathwaysofcancers.Ituseitshighlyefficientdrugdiscoveryengine,whichitrefertoasitsIntegratedDiscoveryEngine,toidentifytargetsanddevelopsmallmoleculenewchemicalentities,orNCEs,withpropertiesthatitbelievecouldresultinpotentiallydifferentiatedproductprofiles.Itsdiscoveryenginecombinesitsextensiveexperienceandcapabilitiesacrosscancerbiologyandmedicinalchemistry.